Schedule 13G ownership disclosure
Allogene Therapeutics Inc
Security class unavailable · CUSIP: 019770106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,030,825
- Percent of class
- 5.3700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-020229
- Form type
- SC 13G
- Filer
- Allogene Therapeutics, Inc.
- CIK
- CIK 1737287
- Filed
- Feb 13, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership